Literature DB >> 30232239

The intestinal microbiota in the pathogenesis of inflammatory bowel diseases: new insights into complex disease.

Katharine G Harris1, Eugene B Chang2.   

Abstract

Inflammatory bowel diseases (IBD) are a group of chronic diseases of increasing worldwide prevalence characterized by gastrointestinal (GI) inflammation leading to debilitating symptoms and complications. The contribution of the intestinal microbiota to the pathogenesis and etiology of these diseases is an area of active research interest. Here, we discuss key mechanisms underlying the chronic inflammation seen in IBD as well as evidence implicating the intestinal microbiota in the development and potentiation of that inflammation. We also discuss recently published work in areas of interest within the field of microbial involvement in IBD pathogenesis - the importance of proper microecology within the GI tract, the evidence that the intestinal microbiota transduces environmental and genetic risk factors for IBD, and the mechanisms by which microbial products contribute to communication between microbe and host. There is an extensive body of published research on the evidence for microbial involvement in IBD; the goal of this review is to highlight the growing edges of the field where exciting and innovative research is pushing the boundaries of the conceptual framework of the role of the intestinal microbiota in IBD pathogenesis.
© 2018 The Author(s). Published by Portland Press Limited on behalf of the Biochemical Society.

Entities:  

Keywords:  Inflammatory bowel disease; inflammation; intestinal microbiota

Mesh:

Year:  2018        PMID: 30232239     DOI: 10.1042/CS20171110

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  15 in total

1.  Microbiota maintain colonic homeostasis by activating TLR2/MyD88/PI3K signaling in IL-10-producing regulatory B cells.

Authors:  Yoshiyuki Mishima; Akihiko Oka; Bo Liu; Jeremy W Herzog; Chang Soo Eun; Ting-Jia Fan; Emily Bulik-Sullivan; Ian M Carroll; Jonathan J Hansen; Liang Chen; Justin E Wilson; Nancy C Fisher; Jenny Py Ting; Tomonori Nochi; Angela Wahl; J Victor Garcia; Christopher L Karp; R Balfour Sartor
Journal:  J Clin Invest       Date:  2019-06-18       Impact factor: 14.808

Review 2.  Characteristics of inflammatory bowel diseases in patients with concurrent immune-mediated inflammatory diseases.

Authors:  Shintaro Akiyama; Soma Fukuda; Joshua M Steinberg; Hideo Suzuki; Kiichiro Tsuchiya
Journal:  World J Gastroenterol       Date:  2022-07-07       Impact factor: 5.374

Review 3.  Inflammatory bowel disease: between genetics and microbiota.

Authors:  Nour Younis; Rana Zarif; Rami Mahfouz
Journal:  Mol Biol Rep       Date:  2020-02-21       Impact factor: 2.316

4.  Spatial and Temporal Analysis of the Stomach and Small-Intestinal Microbiota in Fasted Healthy Humans.

Authors:  Anna M Seekatz; Matthew K Schnizlein; Mark J Koenigsknecht; Jason R Baker; William L Hasler; Barry E Bleske; Vincent B Young; Duxin Sun
Journal:  mSphere       Date:  2019-03-13       Impact factor: 4.389

5.  Astragaloside IV alleviates the symptoms of experimental ulcerative colitis in vitro and in vivo.

Authors:  Suxiao Wu; Zilan Chen
Journal:  Exp Ther Med       Date:  2019-08-16       Impact factor: 2.447

Review 6.  Inflammatory Bowel Disease: A Potential Result from the Collusion between Gut Microbiota and Mucosal Immune System.

Authors:  Bei Yue; Xiaoping Luo; Zhilun Yu; Sridhar Mani; Zhengtao Wang; Wei Dou
Journal:  Microorganisms       Date:  2019-10-11

Review 7.  Manipulating resident microbiota to enhance regulatory immune function to treat inflammatory bowel diseases.

Authors:  Yoshiyuki Mishima; Ryan Balfour Sartor
Journal:  J Gastroenterol       Date:  2019-09-03       Impact factor: 7.527

Review 8.  Asthma and obesity: endotoxin another insult to add to injury?

Authors:  Nikita Lad; Alice M Murphy; Cristina Parenti; Carl P Nelson; Neil C Williams; Graham R Sharpe; Philip G McTernan
Journal:  Clin Sci (Lond)       Date:  2021-12-22       Impact factor: 6.124

9.  Developmental intestinal microbiome alterations in canine fading puppy syndrome: a prospective observational study.

Authors:  Smadar Tal; Evgenii Tikhonov; Omry Koren; Sharon Kuzi; Itamar Aroch; Lior Hefetz; Sondra Turjeman
Journal:  NPJ Biofilms Microbiomes       Date:  2021-06-23       Impact factor: 7.290

10.  Dietary Alaska Pollock Protein Attenuates the Experimental Colitis Induced by Dextran Sulfate Sodium via Regulation of Gut Microbiota and Its Metabolites in Mice.

Authors:  Genki Tanaka; Nozomi Hagihara; Ryota Hosomi; Takaki Shimono; Seiji Kanda; Toshimasa Nishiyama; Munehiro Yoshida; Kenji Fukunaga
Journal:  Metabolites       Date:  2022-01-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.